PARP inhibitors: Synthetic lethality in the clinic.
Lord CJ, Ashworth A.
Science. 2017 Mar 17;355(6330):1152-1158. doi: 10.1126/science.aam7344. Epub 2017 Mar 16.
Potential lethal damage repair in glioblastoma cells irradiated with ion beams of various types and levels of linear energy transfer.
Chew MT, Nisbet A, Suzuki M, Matsufuji N, Murakami T, Jones B, Bradley DA.
J Radiat Res. 2019 Jan 1;60(1):59-68. doi: 10.1093/jrr/rry081.
ERRATUM.
Mini E, Landini I, Lucarini L, Lapucci A, Napoli C, Perrone G, Tassi R, Masini E, Moroni F, Nobili S.
Oncol Res. 2018 Mar 5;26(2):333-334. doi: 10.3727/096504018X15187172557369.
DNA damage and repair.
Ward JF.
Basic Life Sci. 1991;58:403-15; discussion 415-21. doi: 10.1007/978-1-4684-7627-9_15.
DNA Damage Repair and Current Therapeutic Approaches in Gastric Cancer: A Comprehensive Review.
Wang M, Xie C.
Front Genet. 2022 Aug 12;13:931866. doi: 10.3389/fgene.2022.931866. eCollection 2022.
Damage removal and gap filling in nucleotide excision repair.
Kemp MG.
Enzymes. 2019;45:59-97. doi: 10.1016/bs.enz.2019.06.001. Epub 2019 Jul 13.
Membrane damage and repair: a thin line between life and death.
Barisch C, Holthuis JCM, Cosentino K.
Biol Chem. 2023 Feb 23;404(5):467-490. doi: 10.1515/hsz-2022-0321. Print 2023 Apr 25.
Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer.
Yao Y, Lv H, Zhang M, Li Y, Herman JG, Brock MV, Gao A, Wang Q, Fuks F, Zhang L, Guo M.
Front Med. 2024 Aug;18(4):721-734. doi: 10.1007/s11684-023-1053-3. Epub 2024 Jun 27.
DNA damage response and potential biomarkers of radiosensitivity in head and neck cancers: clinical implications.
Carpov D, Buigă R, Nagy VM.
Rom J Morphol Embryol. 2023 Jan-Mar;64(1):5-13. doi: 10.47162/RJME.64.1.01.
DNA mismatch repair and oxidative DNA damage: implications for cancer biology and treatment.
Bridge G, Rashid S, Martin SA.
Cancers (Basel). 2014 Aug 5;6(3):1597-614. doi: 10.3390/cancers6031597.
